Rare cases were reported in patients treated with topical calcineurin inhibitors, including ELIDEL Cream; a causal relationship has not been established, and the section describes a potential risk.
Authority
DailyMed, U.S. National Library of Medicine
Document
ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
Based on this information and the mechanism of action, there is a concern about a potential risk with the use of topical calcineurin inhibitors, including ELIDEL Cream.
While a causal relationship has not been established, rare cases of skin malignancy and lymphoma have been reported in patients treated with topical calcineurin inhibitors, including ELIDEL Cream.
Section
Not stated
Context
Rare cases were reported in patients treated with topical calcineurin inhibitors, including ELIDEL Cream; a causal relationship has not been established, and the section describes a potential risk.